🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this proof-of-concept study is to assess the safety and effe...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-08
Trial ID
NCT01441635
Treatments Being Tested
This study seeks to evaluate the efficacy, safety and tolerability of elago...
Status
Completed
Location
Summers, Birmingham, AL /ID# 139684
Start Date
2015-12-22
Trial ID
NCT02654054
This randomized multicenter phase 3b study seeks to evaluate the safety of ...
Status
Completed
Location
Alabama Clinical Therapeutics /ID# 160835
Start Date
2017-09-13
Trial ID
NCT03271489
Treatments Being Tested
This study seeks to evaluate the efficacy, safety and tolerability of elago...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC /ID# 152258
Start Date
2016-02-03
Trial ID
NCT02691494
This is an extension study for women who have already received six months o...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC /ID# 153217
Start Date
2016-09-14
Trial ID
NCT02925494
Treatments Being Tested
This is a phase 3, multicenter, double-blind, placebo-controlled, randomize...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-09-14
Trial ID
NCT06076486
Treatments Being Tested
The main objective of this study is to assess safety and efficacy of elagol...
Status
Completed
Location
ACCEL Research Sites /ID# 209714
Start Date
2019-04-12
Trial ID
NCT03886220
This is a Phase 2b randomized, double-blind, placebo-controlled study evalu...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-08
Trial ID
NCT01817530
The purpose of this study is to evaluate elagolix (NBI-56418) compared to p...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-12
Trial ID
NCT00973973
Twenty-six otherwise healthy adults between 18-40 years of age composed of ...
Status
Completed
Location
University of Wisconsin
Start Date
2024-07-24
Trial ID
NCT06253702
Treatments Being Tested